Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril
Cardiovascular Drugs and TherapyPublished 1 March 1996
Doron Schwartz, Ran Kornowski, Idit F. Schwartz, Iris Dotan, Baruch Weinreb, Mordechai Averbuch
Citations5
SJR quartileQ1
SJR score1.00
SNIP1.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Measurement of pretreatment PRA levels might be a useful laboratory tool for predicting the renal safety of captopril use in patients with CHF whose EF ≥30%.
Abstract
This study assessed the usefulness of the oral captopril test in the prediction of renal impairment among elderly patients with congestive heart failure (CHF). Forty-seven patients aged > or = 65 years with CHF (EF or = 30%. All these correlations were not statistically significant in the patients with an ejection fraction or = 30%.
Keywords
Medicine
The Nephron journals/Nephron journalsShould We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
11,735 Citations2016Aimun Ahmed, Tom Jorna +1 more
The STOP ACEi trial will strengthen the evidence base and shed light on the potential merits and dangers of ACEi/ARB use in advanced CKD on renal function and cardiovascular outcomes.
New England Journal of MedicineEffect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
8,006 Citations1991The SOLVD Investigators*
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
New England Journal of MedicineEffect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
5,925 Citations1992Marc A. Pfeffer, Eugene Braunwald +16 more
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
New England Journal of MedicineEffects of Enalapril on Mortality in Severe Congestive Heart Failure
5,077 Citations1987The Consensus Trial Study Group*
It is concluded that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms and a significant improvement in NYHA classification was observed in the enAlapril group.
The American Journal of CardiologyEffects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
3,778 Citations1988Karl Swedberg, John Kjekshus
The addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms, and the effect seems to be due to a reduction in death from progression of heart failure.
New England Journal of MedicineComparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
298 Citations1986Milton Packer, Carolina Oi Lam Ung +2 more
It is concluded that when large, fixed doses of converting-enzyme inhibitors are used in the treatment of patients with severe chronic heart failure, long- acting agents may produce prolonged hypotensive effects that may compromise cerebral and renal function, and thus they may have disadvantages in such cases, as compared with short-acting agents.
The American Journal of MedicineThe captopril test for identifying renovascular disease in hypertensive patients
226 Citations1986Franco Müller, Jean E. Sealey +6 more
It is demonstrated that the renin response to oral captopril is a useful screening test for identifying patients with unilateral or bilateral renovascular disease and since the test also characterizes the ren in dependency of the hypertension, it may have other diagnostic and therapeutic uses.
Annals of Internal MedicineFunctional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure
216 Citations1987Milton Packer, Carolina Oi Lam Ung +3 more
The deterioration of renal function after converting-enzyme inhibition in heart failure is not a toxic or immunologic reaction to therapy but results from specific hemodynamic events that can be ameliorated by sodium repletion.
Circulation ResearchRole of angiotensin II in the altered renal function of congestive heart failure.
192 Citations1984Iekuni Ichikawa, J M Pfeffer +3 more
The renal cortical microcirculatory and proximal tubule functions of rats with congestive heart failure are profoundly influenced by the vasoconstrictor properties of angiotensin II.
American Heart JournalRenin relationships in congestive cardiac failure, treated and untreated
174 Citations1970J. J. Brown, D. L. Davies +3 more
A hypothesis is put forward in which a renin-mediated selective reduction of renal inner-medullary blood flow in cardiac failure might be responsible for the disproportion between the high urinary osmolality in relation to that of plasma, and for oliguria, uremia, and hyponatremia.
American Journal of Physiology-Renal PhysiologyVasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2
99 Citations1994Thomas L. Pallone
The results demonstrate that OMDVR are vasoactive segments, and their anatomical arrangement suggests that they play a key role in the regulation of total and regional blood flow to the renal medulla.
Journal of Clinical InvestigationTransport of sodium and urea in outer medullary descending vasa recta.
93 Citations1994Thomas L. Pallone, Jack Work +2 more
Electron microscopic examination of seven in vitro perfused OMVR revealed no fenestrations and exposure of these vessels to 10 microM calcium ionophore A23187 or 1 nM angiotensin II resulted in reversible contraction, suggesting that in vitro performed OMVR are DVR only.
Journal of the American College of CardiologyIdentification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure
86 Citations1987Milton Packer, Wai Hung Lee +4 more
Only hyponatremia (or an elevated plasma renin activity) and enalapril therapy independently predicted the decline in creatinine clearance during converting enzyme inhibition, and these observations could not be explained by changes in systemic blood pressure.
American Journal of Physiology-Renal PhysiologyControl of glomerular filtration rate: role of intrarenally formed angiotensin II
86 Citations1984Philip R. Kastner, John E. Hall +1 more
Results suggest that intrarenal ANG II formation plays an important role in maintaining GFR during reductions in RAP by constricting efferent arterioles.
American Journal of Physiology-Renal PhysiologyGlomerular adaptations to chronic dietary salt restriction or excess
85 Citations1980N. Schor, Iekuni Ichikawa +1 more
The pressor response to infusion of exogenous angiotensin II (AII) was less in group 1 than in group 2, suggesting that vascular receptors for AII may have been occupied by endogenous hormone, the latter leading to the efferent arteriolar vasoconstriction.
American Journal of Physiology-Renal PhysiologyEffects on renal hemodynamics of intra-arterial infusions of angiotensins I and II
57 Citations1983László Rosivall, L. Gabriel Navar
Results indicate that during intra-arterial infusion of ANG I, the conversion to ANG II within the kidney occurs early enough to decrease glomerular filtration rate through an apparent increase in preglomerular resistance.
The American Journal of CardiologyWhy do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition
50 Citations1987Milton Packer
Archives of Internal MedicineRenal Hemodynamic Consequences of Angiotensin-Converting Enzyme Inhibition in Congestive Heart Failure
44 Citations1989Wadi N. Suki
The use of shorter-acting agents in patients who exhibit deterioration in renal function may be preferable, and long-acting ACE inhibitors prolong the decreased efferent arteriolar tone and may compromise cardiac muscle response to catecholamines.
American Journal of Physiology-Renal PhysiologySuperficial nephron responses to peritubular capillary infusions of angiotensins I and II
40 Citations1987Kenneth D. Mitchell, L. Gabriel Navar
Data indicate that conversion of ANG I to ANG II can occur in the peritubular capillary or interstitial environment and that increases above the normal endogenous levels in the postglomerular interstitial ANG II concentration can enhance proximal tubular reabsorption and increase preglomerular resistance and thereby reduce SNGFR.
European Heart JournalWhy do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition
31 Citations1990Milton Packer
I have never yet examined the body of a patient dying of dropsy attended by coagulable urine, in whom some obvious derangement was not discovered in the kidneys.
BMJSevere hyponatraemia and cardiac failure successfully treated with captopril.
21 Citations1982Alison Montgomery, Alan Shepherd +1 more
The glycosylated haemoglobin concentration in a diabetic clinic is measured using a microcolumn method similar to that used in the determination of HbA, determination.
European Heart JournalConverting enzyme inhibitors in heart failure
9 Citations1988M. Gary Nicholls, Hamid Ikram +2 more
The renin-angiotensin system is activated in heart failure in proportion to the severity of the haemodynamic derangement and to diuretic dose, and changes in glomerular filtration rate are dictated by haemodynamics characteristics and, again, by diuresis, dietary sodium.
CHEST JournalRenal Toxicity of Enalapril in Very Elderly Patients with Progressive, Severe Congestive Heart Failure
6 Citations1991Down Schwartz, Mordechai Averbuch +3 more
The data suggest that enalapril can be safely administered to very old patients with rapidly progressive congestive heart failure provided that the initial serum creatinine level is below 1.9 mg/dl.
Upsala Journal of Medical SciencesInfluence of Captopril on Red Cell Velocity in the Vasa Recta of the Renal Medulla
3 Citations1993Peter Hansell
Results give further support to the suggestion of an involvement of AII in the regulation of juxtamedullary vascular resistance in anaesthetized rats during normal physiological conditions.